As the proportion of CD19+ B cells from non-lesions of erythrodermic psoriasis wasquite low (<1%), we used the data obtained from flow cytometry for the expressionof CD19+ B cell surface activation markers, which are shown in Figure 5. This evidence concerns the gene CD19 and psoriasis.